BA vs TRDA · P/E 89, rev $89.46B vs P/E 12, rev $210.8M
The Boeing Company (BA) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
The Boeing Company (BA) is a aerospace & defense company listed on NYSE. It is led by Kelly Ortberg.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported BA revenue for 2025-12-31 was $89.46B. Net income was $2.23B. Revenue was up 34.5% from 2024-12-31 to 2025-12-31. BA currently screens at market cap $177.86B and trailing P/E 89.2.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
BA currently screens at market cap $177.86B and trailing P/E 89.2. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the BA and TRDA stock pages for the full models.
Not investment advice.